Filing Details
- Accession Number:
- 0001144204-10-034419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-21 13:00:00
- Reporting Period:
- 2010-06-17
- Filing Date:
- 2010-06-21
- Accepted Time:
- 2010-06-21 20:22:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326190 | Pharmathene Inc | PIP | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1313876 | I Eric Richman | C/O Pharmathene, Inc., One Park Place, Suite 450 Annapolis MD 21401 | President And Interim Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2010-06-17 | 10,000 | $1.58 | 70,573 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.58 per share. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on June 17, 2010.